Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Mar-24 10:00 PM View:  | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 24,844 | $0.72 | $17,887.70 | (1%) 1.94M to 1.91M | |
| 09-Jan-24 4:41 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 1,280,000 | -- | -- | 195% 655.5K to 1.94M | |
| 18-Aug-23 6:25 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 30,766 | $1.65 | $50,834.80 | (4%) 706.67K to 675.9K | |
| 29-Jun-23 4:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-23 | Sale | 14,291 | $1.66 | $23,723.10 | (2%) 720.96K to 706.67K | |
| 18-May-23 8:17 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 29,766 | $2.04 | $60,633.30 | (4%) 750.73K to 720.96K | |
| 06-Mar-23 6:49 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 15,679 | $3.63 | $56,867.70 | (2%) 766.41K to 750.73K | |
| 03-Mar-23 5:16 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 324,711 | -- | -- | 74% 441.7K to 766.41K | |
| 18-Nov-22 8:13 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-22 | Sale (Planned) | 15,591 | $4.49 | $70,003.60 | (3%) 457.29K to 441.7K | |
| 18-Aug-22 6:24 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-22 | Sale (Planned) | 14,806 | $5.03 | $74,548.20 | (3%) 472.09K to 457.29K | |
| 29-Jun-22 4:48 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-22 | Sale (Planned) | 14,220 | $7.20 | $102,384.00 | (3%) 486.31K to 472.09K | |
| 19-May-22 5:04 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-May-22 | Sale (Planned) | 13,913 | $5.32 | $73,961.50 | (3%) 500.23K to 486.31K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Grant | 180,565 | -- | -- | 55% 328.49K to 509.05K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Sale (Planned) | 8,828 | $9.86 | $87,008.80 | (2%) 509.05K to 500.23K | |
| 18-Nov-21 5:55 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-21 | Market Sale (Planned) | 8,402 | $17.12 | $143,816.00 | (2%) 336.89K to 328.49K | (4%) |
| 19-Aug-21 7:37 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Aug-21 | Market Sale (Planned) | 8,223 | $12.53 | $103,051.00 | (2%) 345.11K to 336.89K | < 1% |
| 29-Jun-21 4:06 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 25-Jun-21 | Market Sale (Planned) | 14,194 | $16.32 | $231,660.00 | (4%) 359.31K to 345.11K | 2% |
| 20-May-21 4:31 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-21 | Market Sale (Planned) | 8,313 | $14.55 | $120,954.00 | (2%) 367.62K to 359.31K | 4% |
| 04-Mar-21 4:06 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-21 | Market Sale (Planned) | 4,887 | $16.74 | $81,808.40 | (1%) 372.51K to 367.62K | 5% |
| 03-Mar-21 5:13 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-21 | Grant | 117,187 | -- | -- | 46% 255.32K to 372.51K | |
| 18-Nov-20 4:07 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Nov-20 | Market Sale (Planned) | 4,716 | $19.77 | $93,254.20 | (2%) 260.04K to 255.32K | (14%) |
| 20-Aug-20 7:39 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-Aug-20 | Market Sale (Planned) | 4,807 | $12.09 | $58,116.60 | (2%) 264.84K to 260.04K | (86%) |
| 26-Jun-20 4:18 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 25-Jun-20 | Market Sale (Planned) | 12,135 | $12.92 | $156,784.00 | (4%) 276.98K to 264.84K | (74%) |
| 20-May-20 6:10 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-20 | Market Sale (Planned) | 3,195 | $11.22 | $35,847.90 | (1%) 280.17K to 276.98K | (101%) |
| 03-Mar-20 4:59 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-20 | Grant | 150,000 | -- | -- | 115% 130.17K to 280.17K | |
| 28-Jan-20 4:31 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 24-Jan-20 | Payment of Exercise | 9,900 | $13.62 | $134,838.00 | (7%) 140.07K to 130.17K | (66%) |
| 25-Jun-19 4:20 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 24-Jun-19 | Grant | 140,074 | -- | -- | 100% 0 to 140.07K |